Indication and Techniques of Transcatheter Closure of Patent Foramen Ovale

Journal of Interventional Cardiology

Volumn 16, Issue 6, 2003, Pages 543-551

  Schräder, Rainer ^a  

^a Medizinische Klinik III CCB   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

BRAIN ISCHEMIA; CLINICAL TRIAL; CONFERENCE PAPER; CORRELATION ANALYSIS; EMBOLISM; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STANDARDIZATION; TREATMENT OUTCOME;

BALLOON DILATATION; BRAIN ISCHEMIA; EMBOLISM, PARADOXICAL; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; PROSTHESES AND IMPLANTS; RECURRENCE; RISK FACTORS;

EID: 10744222807     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8183.2003.01054.x     Document Type: Conference Paper

References (47)

1. Cohnheim J. In Thrombose und Embolie: Vorlesung über allgemeine Pathologie. Berlin, Germany: Hirschwald, Berlin, 1877:134.
2. King TD, Mills NL Nonoperative closure of atrial septal defects. Surgery 1974;75(3):383-388.
3. King TD, Mills NL. Secundum atrial septal defect: Nonoperative closure during cardiac catheterization. JAMA 1976;235:2506-2509.
4. King TD. Thompson SL, Mills NL. Measurement of atrial septal defect during cardiac catheterization: Experimental and clinical trials. Am J Cardiol 1978;41:537-542.
5. Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-1908.
6. Berger F, Uhlemann F, Nürnberg JH, et al. Transkatheterverschluß des persistierenden Foramen ovale als Möglichkeit zur Vermeidung paradoxer Embolien? Dtsch med Wschr 1997;122:1371-1376.
7. Rux S, Keppeler P, Dirks J, et al. Interventioneller Verschluß des persistierenden Foramen ovale bei 71 Patienten mit vermuteten paradoxen Embolien: Ein Vergleich zwischen vier verschiedenen Okklusions-Systemen. J Kardiol 1999;6:17-22.
8. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311-1316.
9. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism. Long-term risk of recurrent thrombembolic events. Circulation 2000;101:893-898.
10. Butera G, Bini MR, Chessa M, et al. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Ital Heart J 2001;2:115-118.
11. Sievert H, Horvath K, Zadan E, et al. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interven Cardiol 2001;14:261-266.
12. Du ZD, Cao QL, Joseph A, et al. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: Intermediate-term risk of recurrent neurological events. Catheter Cardiovasc Interv 2002;55:189-194.
13. Braun MU, Fassbender D, Schoen SP, et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
14. Beitzke A, Schuchlenz M, Gamillscheg A, et al. Interventioneller Verschluss von Foramen ovale und Vorhofseptumdefekten nach paradox embolischen Ereignissen. Z Kardiol 2002;91:693-700.
15. Daniel WG. Transcatheter closure of patent foramen ovale: Therapeutic overkill or elegant management for selected patients at risk. Circulation 1992;86:2013-2015.
16. Windecker S, Meier B. Percutaneous foramen ovale closure: It can be done but should it? Catheter Cardiovasc Interv 1999;47:377-380.
17. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
18. Droste DW, Ringelstein EB. Detection of high intensity transient signals (HITS): How and why? Eur J Ultrasound 1998;7:23-29.
19. Hart RG, Miller VT. Cerebral infarction in young adults: A practical approach. Stroke 1983;14:110-114.
20. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: The NINCDS Stroke Data Bank. Ann Neurol 1989;25:382-390.
21. Steiner MM, Di Tullio MR, Rundek T, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-948.
22. Hausmann D, Mügge A, Becht I, et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992;70:668-672.
23. Webster MV, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1998;2:11-12.
24. Lechat P, Mas JL, Lascult G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
25. De Belder MA, Tourikis L, Leech G, et al. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 1992;69:1316-1320.
26. Di Tullio M, Sacco RL, Gopal A, et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-465.
27. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993;24:1865-1873.
28. Jones EF, Calafiore P, Donnan GA, et al. Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol 1994;74:596-599.
29. Overall JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
30. Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: The SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 1999;74:862-869.
31. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
32. Homma S, Di Tullio MR, Sacco RL, et al. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994;25:582-586.
33. Mohr JP, Thompson JL, Lazar RM, et al. For the Warfarin-Aspirin Recurrent Stroke Study Group: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. New Engl J Med 2001;345:1444-1451.
34. Comess KA, De Rook FA, Beach KW, et al. Transesophageal echodardiography and carotid ultrasound in patients with cerebral ischemia: Prevalence of findings and recurrent stroke risk. J Am Coll Cardiol 1994;23:1598-1603.
35. Hanna JP, Sun JP, Furlan AJ, et al. Patent foramen ovale and brain infarct: Echocardiographic predictors, recurrence, and prevention. Stroke 1994;25:782-786.
36. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneursym, or both and cryptogenic stroke or transient ischemic attack. French study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995;130:1083-1088.
37. Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996;46:1301-1305.
38. De Castro S, Cartoni D, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-2413.
39. Homma S, Sacco RL, DiTullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale. Patent foramen ovale in cryptogenic stroke study. Circulation 2002;105:2625-2631.
40. Knauth M, Ries S, Phimann S, et al. Cohort study of multiple brain lesions in sport divers: Role of a patent foramen ovale. BMJ 1997;314:701-705.
41. Schwerzmann M, Seiler C, Lipp E, et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 2001;134:21-24.
42. Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
43. Sharafuddin MJ, Gu X, Titus JL, et al. Transvenous closure of secundum atrial septal defects: Preliminary results with a new self-expanding nitinol prothesis in a swine model. Circulation 1997;95:2162-2168.
44. Das GS, Voss G, Jarvis G, et al. Experimental atrial septal defect closure with a new, transcatheter, self-centering device. Circulation 1993;88:1754-1764.
45. Babic UU, Grujicic S, Djurisic Z, et al. Transcatheter closure of atrial septal defects. Lancet 1990;336:566-567.
46. Sideris EB, Sideris SE, Fowlkes JP, et al. Transvenous atrial septal defect occlusion in piglets with a "buttoned" double-disk-device. Circulation 1990;81:312-318.
47. Teupe C, Schneider M, Nacimiento W, et al. Interventioneller Verschluß eines offenen Foramen ovale bei einer Patientin mit rezidivierenden zerebralen Ischämien. Nervenarzt 1995;66:634-637.